Home › Prostate Cancer › California › Torrance
Prostate Cancer clinical trials in Torrance, CA
3 studies for Prostate Cancer are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- UCLA Hematology/Oncology - Torrance, Torrance
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Torrance Memorial Physician Network - Cancer Care, Torrance
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- City of Hope South Bay, Torrance
- Torrance Memorial Physician Network - Cancer Care, Torrance
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer9 studies
- Overweight9 studies
- Obesity9 studies
- Lung Cancer7 studies
- Cardiovascular Disease7 studies
- Bladder Cancer7 studies
- Schizophrenia6 studies
- Heart Failure5 studies
- Atherosclerosis5 studies
- Metastatic Cancer4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.